09/04/2026
What happens when a prescription costs more than a family can manage?
For Paul Pruitt, this is personal. In a recent news interview, SHARx’s Co-Founder and Chief Growth Officer shares his family’s experience navigating the cost of medications for his two sons, who live with a rare genetic disease.
The conversation highlights the growing pressure prescription drug costs place on families and employers, and why a better approach to prescription benefits is needed.
Watch the full interview: 🔗
In this segment featured on CBS’ 8 NewsNow, SHARx Co-Founder and Chief Growth Officer Paul Pruitt discusses the growing burden of prescription drug costs, drawing on both his professional experience and his family’s personal experience with a rare genetic disease. The conversation explores the c...